ULBP2 and COVID-19: For example, severe COVID-19 patients had higher levels of the soluble form of ULBP2, a ligand for the NKG2D receptor on NK cells that mediates mediating cytotoxicity, which inhibits NK-cells as a mechanism to evade immunosurveillance by NK cells21,22.